Previous Close | 140.38 |
Open | 144.05 |
Bid | 0.00 x 1200 |
Ask | 237.95 x 800 |
Day's Range | 142.41 - 150.96 |
52 Week Range | 130.96 - 293.20 |
Volume | |
Avg. Volume | 276,295 |
Market Cap | 5.634B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | 167.58 |
EPS (TTM) | 0.90 |
Earnings Date | May 02, 2022 - May 06, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 258.50 |
If you want to know who really controls Penumbra, Inc. ( NYSE:PEN ), then you'll have to look at the makeup of its...
Penumbra Inc (NYSE: PEN) reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance. Wells Fargo lowered the price target to $265 from 321, which is equivalent to a 52.2% upside. At 9.5x (down from 12x as peer group valuation has been compressed) with a 2023 sales estimate of $1.02 billion, PEN shares would trade essentially in line with its peers, analysts write. Q1 revenue of $203.9 million (+21.8% ex-FX) beat the consensus of $195.04 m
Penumbra (PEN) delivered earnings and revenue surprises of -116.67% and 4.03%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?